参考文献/References:
[1] Park S,Jeon JH,Min BK,et al.Role of the pyruvate dehydrogenase complex in metabolic remodeling:Differential pyruvate dehydrogenase complex functions in metabolism[J].Diabetes Metab J,2018,42(4):270-281.
[2] Kolobova E,Tuganova A,Boulatnikov I,et al.Regulation of pyruvate dehydrogenase activity through phosphorylation at multiple sites[J].Biochem J,2001,358(Pt 1):69-77.
[3] Gray LR,Tompkins SC,Taylor EB.Regulation of pyruvate metabolism and human disease[J].Cell Mol Life Sci,2014,71(14):2577-2604.
[4] Atas E,Oberhuber M,Kenner L.The implications of PDK1-4 on tumor energy metabolism,aggressiveness and therapy resistance[J].Front Oncol,2020,10:583217.
[5] Wang L,Sahlin K.The effect of continuous and interval exercise on PGC-1alpha and PDK4 mRNA in type I and type Ⅱ fibres of human skeletal muscle[J].Acta Physiol(Oxf),2012,204(4):525-532.
[6] Wu P,Blair PV,Sato J,et al.Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues[J].Arch Biochem Biophys,2000,381(1):1-7.
[7] Lee IK.The role of pyruvate dehydrogenase kinase in diabetes and obesity[J].Diabetes Metab J,2014,38(3):181-186.
[8] Kon S,Ishibashi K,Katoh H,et al.Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes[J].Nat Cell Biol,2017,19(5):530-541.
[9] Miao Y,Li Q,Sun G,et al.MiR-5683 suppresses glycolysis and proliferation through targeting pyruvate dehydrogenase kinase 4 in gastric cancer[J].Cancer Med,2020,9(19):7231-7243.
[10] Guo K,Zhang Y,Liu L,et al.LncRNA SNHG12 promotes the development and progression of colon cancer by regulating the miR-15a/PDK4 axis[J].Am J Transl Res,2021,13(9):10233-10247.
[11] Liu B,Yan L,Chi Y,et al.Long non-coding RNA AFAP1-AS1 facilitates ovarian cancer progression by regulating the miR-107/PDK4 axis[J].J Ovarian Res,2021,14(1):60.
[12] Liu Y,Qiu S,Zheng X,et al.LINC00662 modulates cervical cancer cell proliferation,invasion,and apoptosis via sponging miR-103a-3p and upregulating PDK4[J].Mol Carcinog,2021,60(6):365-376.
[13] Huang Y,Zheng S,Lin Y,et al.Circular RNA circ-ERBB2 elevates the warburg effect and facilitates triple-negative breast cancer growth by the microRNA 136-5p/pyruvate dehydrogenase kinase 4 axis[J].Mol Cell Biol,2021,41(10):e0060920.
[14] Ren H,Song Z,Chao C,et al.circCCDC66 promotes thyroid cancer cell proliferation,migratory and invasive abilities and glycolysis through the miR-211-5p/PDK4 axis[J].Oncol Lett,2021,21(5):416.
[15] Qin YJ,Lin TY,Lin XL,et al.Loss of PDK4 expression promotes proliferation,tumorigenicity,motility and invasion of hepatocellular carcinoma cells[J].J Cancer,2020,11(15):4397-4405.
[16] Li G,Li M,Hu J,et al.The microRNA-182-PDK4 axis regulates lung tumorigenesis by modulating pyruvate dehydrogenase and lipogenesis[J].Oncogene,2017,36(7):989-998.
[17] Oberhuber M,Pecoraro M,Rusz M,et al.STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer[J].Mol Syst Biol,2020,16(4):e9247.
[18] Yang C,Wang S,Ruan H,et al.Downregulation of PDK4 increases lipogenesis and associates with poor prognosis in hepatocellular carcinoma[J].Journal of Cancer,2019,10(4):918-926.
[19] Cui Z,Wang Q,DENG MH,et al.LncRNA HCG11 promotes 5-FU resistance of colon cancer cells through reprogramming glucose metabolism by targeting the miR-144-3p-PDK4 axis[J].Cancer Biomark,2021, 34(1):41-53.
[20] Jiang D,Mo Q,Sun X,et al.Pyruvate dehydrogenase kinase 4-mediated metabolic reprogramming is involved in rituximab resistance in diffuse large B-cell lymphoma by affecting the expression of MS4A1/CD20[J].Cancer Sci,2021,112(9):3585-3597.
[21] Jane EP,Premkumar DR,Rajasundaram D,et al.Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases[J].Mol Oncol,2022,16(1):219-249.
[22] Zhao Z,Ji M,Wang Q,et al.MiR-16-5p/PDK4-Mediated metabolic reprogramming is involved in chemoresistance of cervical cancer[J].Mol Ther Oncolytics,2020,17:509-517.
[23] Song X,Liu J,Kuang F,et al.PDK4 dictates metabolic resistance to ferroptosis by suppressing pyruvate oxidation and fatty acid synthesis[J].Cell Rep,2021,34(8):108767.
[24] Pin F,Novinger LJ,Huot JR,et al.PDK4 drives metabolic alterations and muscle atrophy in cancer cachexia[J].FASEB J,2019,33(6):7778-7790.
[25] Choiniere J,Wu J,Wang L.Pyruvate dehydrogenase kinase 4 deficiency results in expedited cellular proliferation through E2F1-mediated increase of cyclins[J].Mol Pharmacol,2017,91(3):189-196.
[26] Wu J,Zhao Y,Park YK,et al.Loss of PDK4 switches the hepatic NF-kappaB/TNF pathway from pro-survival to pro-apoptosis[J].Hepatology,2018,68(3):1111-1124.
[27] Li X,Wang L,Wang L,et al.Single-Cell sequencing of hepatocellular carcinoma reveals cell interactions and cell heterogeneity in the microenvironment[J].Int J Gen Med,2021,14:10141-10153.
[28] Fekir K,Dubois-Pot-Schneider H,Désert R,et al.Retrodifferentiation of human tumor hepatocytes to stem cells leads to metabolic reprogramming and chemoresistance[J].Cancer Research,2019,79(8):1869-1883.
[29] Han H,Li W,Shen H,et al.microRNA-129-5p,a c-Myc negative target,affects hepatocellular carcinoma progression by blocking the Warburg effect[J].Journal of Molecular Cell Biology,2016,8(5):400-410.
[30] Zhang X,Wu J,Choiniere J,et al.Arsenic silences hepatic PDK4 expression through activation of histone H3K9 methylatransferase G9a[J].Toxicol Appl Pharmacol,2016,304:42-47.
[31] Li Z,Peng Y,Li J,et al.N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4[J].Nat Commun,2020,11(1):2578.
[32] Du D,Liu C,Qin M,et al.Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma[J].Acta Pharm Sin B,2022,12(2):558-580.
[33] Woolbright BL,Choudhary D,Mikhalyuk A,et al.The role of Pyruvate Dehydrogenase Kinase-4(PDK4)in bladder cancer and chemoresistance[J].Mol Cancer Ther,2004,17(9):12.
[34] Weng Y,Shen Y,He Y,et al.The miR-15b-5p/PDK4 axis regulates osteosarcoma proliferation through modulation of the Warburg effect[J].Biochem Biophys Res Commun,503(4):2749-2757.
[35] Zhao Y,Tran M,Wang L,et al.PDK4-Deficiency reprograms intrahepatic glucose and lipid metabolism to facilitate liver regeneration in mice[J].Hepatol Commun,2020,4(4):504-517.
[36] Song K,Kwon H,Han C,et al.Active glycolytic metabolism in CD133+ hepatocellular cancer stem cells:regulation by mIR-122[J].Oncotarget,2015,6(38):40822-40835.